MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma. [electronic resource]
Producer: 20120511Description: 368-72 p. digitalISSN:- 1607-8454
- Adolescent
- Adult
- Aged
- Antigens, Neoplasm -- genetics
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blotting, Western
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- L-Lactate Dehydrogenase -- blood
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Neoplasm Proteins -- genetics
- Neoplasm Staging
- Prognosis
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Analysis
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.